118 related articles for article (PubMed ID: 29066693)
1. [The Impact of Neutrophil-Lymphocyte Ratio on the Prognosis in Patients Who Underwent Esophagectomy for Esophageal Cancer].
Muroya T; Wajima N; Ogasawara H; Yachi T; Akaishi T; Umetsu S; Wakasa Y; Yoshida T; Sato K; Mitsuhashi Y; Umemura K; Suzuki T; Tsuruta S; Hakamada K
Gan To Kagaku Ryoho; 2017 Oct; 44(10):912-914. PubMed ID: 29066693
[TBL] [Abstract][Full Text] [Related]
2. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
[TBL] [Abstract][Full Text] [Related]
3. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.
Nakamura K; Yoshida N; Baba Y; Kosumi K; Uchihara T; Kiyozumi Y; Ohuchi M; Ishimoto T; Iwatsuki M; Sakamoto Y; Watanabe M; Baba H
Int J Clin Oncol; 2017 Jun; 22(3):469-475. PubMed ID: 28097441
[TBL] [Abstract][Full Text] [Related]
4. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma].
Chen H; He J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917
[TBL] [Abstract][Full Text] [Related]
5. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
[TBL] [Abstract][Full Text] [Related]
8. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy.
Kato T; Oshikiri T; Goto H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Suzuki S; Kakeji Y
J Surg Oncol; 2021 Dec; 124(7):1022-1030. PubMed ID: 34460103
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
10. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
11. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract][Full Text] [Related]
12. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.
Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H
Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304
[TBL] [Abstract][Full Text] [Related]
14. Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American Joint Committee on Cancer (AJCC8) staging.
Conway AM; Salih Z; Papaxoinis G; Fletcher K; Weaver J; Patrao A; Noble R; Stamatopoulou S; Owen-Holt V; Mansoor W
Med Oncol; 2017 Jun; 34(6):116. PubMed ID: 28500616
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Importance of Controlling Nutritional Status in Patients Undergoing Curative Thoracoscopic Esophagectomy for Esophageal Cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Nakada S; Tajima Y
Am J Ther; 2018; 25(5):e524-e532. PubMed ID: 26866437
[TBL] [Abstract][Full Text] [Related]
17. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.
Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Kurashige J; Hiyoshi Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Surg Today; 2016 Apr; 46(4):405-13. PubMed ID: 26036223
[TBL] [Abstract][Full Text] [Related]
19. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
Wang X; Li K
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
[TBL] [Abstract][Full Text] [Related]
20. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer.
Tustumi F; Takeda FR; Viyuela MS; da Cruz Junior JB; Brandão AAGS; Sallum RAA; Ribeiro Junior U; Cecconello I
J Surg Oncol; 2020 Apr; 121(5):784-794. PubMed ID: 31762058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
